Literature DB >> 14999233

Molecular biology of prostate cancer.

M K Karayi1, A F Markham.   

Abstract

Development of any cancer reflects a progressive accumulation of alterations in various genes. Oncogenes, tumour suppressor genes, DNA repair genes and metastasis suppressor genes have been investigated in prostate cancer. Here, we review current understanding of the molecular biology of prostate cancer. Detailed understanding of the molecular basis of prostate cancer will provide insights into the aetiology and prognosis of the disease, and suggest avenues for therapeutic intervention in the future.

Entities:  

Mesh：

Year:  2004        PMID： 14999233     DOI： 10.1038/sj.pcan.4500697

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN： 1365-7852            Impact factor:   5.554


  9 in total

1.  Decreased expression of EFS is correlated with the advanced prostate cancer.

Authors:  Selda Sertkaya; Syed Muhammad Hamid; Nihat Dilsiz; Lokman Varisli
Journal:  Tumour Biol       Date:  2014-10-09

Review 2.  Genomics of prostate cancer: is there anything to "translate"?

Authors:  László Kopper; József Tímár
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

3.  Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.

Authors:  Michel D Wissing; Janet Mendonca; Eunice Kim; Eugene Kim; Joong S Shim; Nadine S Kaelber; Huub Kant; Hans Hammers; Therese Commes; Paul J Van Diest; Jun O Liu; Sushant K Kachhap
Journal:  Cancer Biol Ther       Date:  2013-02-01       Impact factor: 4.742

4.  A mathematical approach predicting the number of events in different tumors.

Authors:  Ralf J Rieker; Josef Hoegel; Michael A Kern; Christina Steger; Sebastian Aulmann; Gunhild Mechtersheimer; Peter Schirmacher; Hendrik Blaeker
Journal:  Pathol Oncol Res       Date:  2008-04-23       Impact factor: 3.201

5.  Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling.

Authors:  Julia Kravchenko; Igor Akushevich; Amy P Abernethy; H Kim Lyerly
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

Review 6.  Oxidative stress in prostate hyperplasia and carcinogenesis.

Authors:  Udensi K Udensi; Paul B Tchounwou
Journal:  J Exp Clin Cancer Res       Date:  2016-09-08

7.  Complementary biobank of rodent tissue samples to study the effect of World Trade Center exposure on cancer development.

Authors:  Wil Lieberman-Cribbin; Stephanie Tuminello; Christina Gillezeau; Maaike van Gerwen; Rachel Brody; David J Mulholland; Lori Horton; Maureen Sisco; Colette Prophete; Judith Zelikoff; Hyun-Wook Lee; Sung-Hyun Park; Lung-Chi Chen; Mitchell D Cohen; Emanuela Taioli
Journal:  J Transl Med       Date:  2019-10-11       Impact factor: 5.531

8.  Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.

Authors:  Sourik S Ganguly; Galen Hostetter; Lin Tang; Sander B Frank; Kathylynn Saboda; Rohit Mehra; Lisha Wang; Xiaohong Li; Evan T Keller; Cindy K Miranti
Journal:  Oncogene       Date:  2019-08-29       Impact factor: 9.867

9.  Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer.

Authors:  Sakshi Sikka; Luxi Chen; Gautam Sethi; Alan Prem Kumar
Journal:  PPAR Res       Date:  2012-11-14       Impact factor: 4.964
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.